Glazer Capital’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-17,999
Closed -$768K – 636
2026
Q2
$768K Buy
+17,999
New +$977K 0.02% 294

Other funds holding BSX

Glazer Capital's BSX Position: Q3 2026 in Review

Glazer Capital sold out of Boston Scientific (BSX) in Q3 2026, closing a stake of 17,999 shares — an estimated $768K sold.

Glazer Capital first reported a position in BSX in Q2 2026 and held it in 1 quarter. The position peaked at $768K in Q2 2026. 1,516 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

  • Glazer Capital reported no remaining Boston Scientific position as of Q3 2026 after selling out during the quarter.
  • Glazer Capital sold 17,999 Boston Scientific shares in Q3 2026, an estimated $768K.
  • Glazer Capital first reported a position in Boston Scientific in Q2 2026 and held it in 1 quarter.
  • Glazer Capital's Boston Scientific position peaked at $768K in Q2 2026.
  • 1,516 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on Glazer Capital's 13F filing for Q3 2026, filed 17 Nov 2026.